Revel Pharmaceuticals
生物技术研究
San Francisco,CA 1,959 位关注者
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage.
关于我们
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.
- 网站
-
https://revelpharmaceuticals.com
Revel Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- San Francisco,CA
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
953 Indiana Street
US,CA,San Francisco,94107